Technical Analysis for ALT - Altimmune, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 200 DMA | Bullish | 8.20% | |
| Wide Bands | Range Expansion | 8.20% | |
| MACD Bearish Signal Line Cross | Bearish | 16.60% | |
| 50 DMA Support | Bullish | 16.60% | |
| Crossed Above 20 DMA | Bullish | 16.60% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 16.60% | |
| Calm After Storm | Range Contraction | 16.60% | |
| NR7 | Range Contraction | 16.60% | |
| Inside Day | Range Contraction | 16.60% | |
| Wide Bands | Range Expansion | 16.60% |
| Alert | Time |
|---|---|
| 1.5x Volume Pace | 37 minutes ago |
| Up 5% | 37 minutes ago |
| Rose Above Previous Day's High | 44 minutes ago |
| 60 Minute Opening Range Breakout | about 1 hour ago |
| Up 3% | about 1 hour ago |
Free Daily (Stock) Chart Reading
- Earnings date: 11/12/2024
Altimmune, Inc. Description
Altimmune,Inc., formerly Pharmathene, Inc., is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company's anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes. The Company's product portfolio includes recombinant butyrylcholinesterase (rBChE) bioscavenger, which is used in prevention and treatment of nerve agent poisoning. The Company has developed a recombinant form of human butyrylcholinesterase for pre- and post-exposure therapy to patients with nerve agent attacks. Its rBChE bioscavenger acts with mechanism, which includes reversal of the acute toxicity associated with organophosphate poisoning agents used in chemical warfare (cholinergic crisis). Its development program also includes Valortim for monoclonal human antibody treatment.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Phosphates Manufacturing Process Obesity Vaccines Reversal Nerve Manufacturing Processes Biodefense Choline Biological Warfare Anthrax Chemical Warfare Cholinesterase Anthrax Vaccines Athene
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.84 |
| 52 Week Low | 2.5 |
| Average Volume | 2,883,948 |
| 200-Day Moving Average | 7.59 |
| 50-Day Moving Average | 7.06 |
| 20-Day Moving Average | 7.47 |
| 10-Day Moving Average | 8.02 |
| Average True Range | 0.77 |
| RSI (14) | 55.75 |
| ADX | 28.61 |
| +DI | 39.30 |
| -DI | 24.46 |
| Chandelier Exit (Long, 3 ATRs) | 8.84 |
| Chandelier Exit (Short, 3 ATRs) | 8.77 |
| Upper Bollinger Bands | 9.11 |
| Lower Bollinger Band | 5.84 |
| Percent B (%b) | 0.68 |
| BandWidth | 43.74 |
| MACD Line | 0.31 |
| MACD Signal Line | 0.32 |
| MACD Histogram | -0.0071 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.40 | ||||
| Resistance 3 (R3) | 9.37 | 8.90 | 9.18 | ||
| Resistance 2 (R2) | 8.90 | 8.55 | 8.91 | 9.10 | |
| Resistance 1 (R1) | 8.47 | 8.34 | 8.69 | 8.50 | 9.03 |
| Pivot Point | 8.00 | 8.00 | 8.10 | 8.01 | 8.00 |
| Support 1 (S1) | 7.57 | 7.65 | 7.78 | 7.60 | 7.07 |
| Support 2 (S2) | 7.10 | 7.44 | 7.11 | 7.00 | |
| Support 3 (S3) | 6.67 | 7.10 | 6.92 | ||
| Support 4 (S4) | 6.70 |
